These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16014686)

  • 1. Early T cell activation in the skin from patients with systemic sclerosis.
    Kalogerou A; Gelou E; Mountantonakis S; Settas L; Zafiriou E; Sakkas L
    Ann Rheum Dis; 2005 Aug; 64(8):1233-5. PubMed ID: 16014686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis.
    Manetti M; Neumann E; Müller A; Schmeiser T; Saar P; Milia AF; Endlicher E; Roeb E; Messerini L; Matucci-Cerinic M; Ibba-Manneschi L; Müller-Ladner U
    Arthritis Rheum; 2008 Sep; 58(9):2866-73. PubMed ID: 18759276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD69 on T-cell subsets in HIV-1 disease.
    Pitsios C; Dimitrakopoulou A; Tsalimalma K; Kordossis T; Choremi-Papadopoulou H
    Scand J Clin Lab Invest; 2008; 68(3):233-41. PubMed ID: 17917998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.
    Beşliu AN; Bănică LM; Lonescu R; Predeţeanu D; Stăvaru C; Marica CM; Chiţonu C; Pistol G; Stefănescu M; Matache C
    Roum Arch Microbiol Immunol; 2009; 68(1):5-13. PubMed ID: 19507621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating γ/δ T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts.
    Ueda-Hayakawa I; Hasegawa M; Hamaguchi Y; Takehara K; Fujimoto M
    J Dermatol Sci; 2013 Jan; 69(1):54-60. PubMed ID: 23159281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
    Ebelt K; Babaryka G; Figel AM; Pohla H; Buchner A; Stief CG; Eisenmenger W; Kirchner T; Schendel DJ; Noessner E
    Prostate; 2008 Jan; 68(1):1-10. PubMed ID: 17948280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal T-cell populations are frequent in the skin and blood of patients with systemic sclerosis.
    Kreuter A; Höxtermann S; Tigges C; Hahn SA; Altmeyer P; Gambichler T
    Br J Dermatol; 2009 Oct; 161(4):785-90. PubMed ID: 19523172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis.
    Parel Y; Aurrand-Lions M; Scheja A; Dayer JM; Roosnek E; Chizzolini C
    Arthritis Rheum; 2007 Oct; 56(10):3459-67. PubMed ID: 17907151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid flow cytometric method for measuring lymphocyte subset activation.
    Maino VC; Suni MA; Ruitenberg JJ
    Cytometry; 1995 Jun; 20(2):127-33. PubMed ID: 7664623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunobiology of systemic sclerosis.
    Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
    Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha4beta1 and alpha4beta7 CD4 T cell numbers increase and CLA CD4 T cell numbers decrease in systemic sclerosis.
    Scala E; Paganelli R; Sampogna F; Abeni D; Colonna L; De Pità O; Puddu P; Russo G
    Clin Exp Immunol; 2005 Mar; 139(3):551-7. PubMed ID: 15730402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma.
    Higashi-Kuwata N; Makino T; Inoue Y; Takeya M; Ihn H
    Exp Dermatol; 2009 Aug; 18(8):727-9. PubMed ID: 19320738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased transendothelial migration of scleroderma lymphocytes.
    Stummvoll GH; Aringer M; Grisar J; Steiner CW; Smolen JS; Knobler R; Graninger WB
    Ann Rheum Dis; 2004 May; 63(5):569-74. PubMed ID: 15082489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.
    Cipriani P; Fulminis A; Pingiotti E; Marrelli A; Liakouli V; Perricone R; Pignone A; Matucci-Cerinic M; Giacomelli R
    J Rheumatol; 2006 Oct; 33(10):2003-14. PubMed ID: 17014016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and proliferation of T lymphocyte subpopulations in patients with brucellosis.
    Moreno-Lafont MC; López-Santiago R; Paredes-Cervantes V; Estrada-Aguilera A; Santos-Argumedo L
    Arch Med Res; 2003; 34(3):184-93. PubMed ID: 14567397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity.
    Beeler A; Zaccaria L; Kawabata T; Gerber BO; Pichler WJ
    Allergy; 2008 Feb; 63(2):181-8. PubMed ID: 18005225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell repertoire in patients with stable scleroderma.
    Tiev KP; Abriol J; Burland MC; Antonelli D; Klatzmann D; Cabane J; Boyer O
    Clin Exp Immunol; 2005 Feb; 139(2):348-54. PubMed ID: 15654834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of activated complement complex C5b-9 and complement receptor C5a in skin biopsies of patients with systemic sclerosis (scleroderma).
    Sprott H; Müller-Ladner U; Distler O; Gay RE; Barnum SR; Landthaler M; Schölmerich J; Lang B; Gay S
    J Rheumatol; 2000 Feb; 27(2):402-4. PubMed ID: 10685805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.